Total population (n=450) |
HPV type |
+/+ |
+/- |
-/+ |
-/- |
Agreement [%] |
Kappa [95% CI] |
|
hrHPV |
241 |
15 |
29 |
164 |
90.2 |
0.798 (0.742 -
0.855) |
|
HPV16 |
60 |
7 |
10 |
372 |
96.2 |
0.854 (0.786 -
0.921) |
|
HPV18 |
13 |
2 |
4 |
430 |
98.7 |
0.806 (0.654 - 0.957) |
|
Other hrHPV |
185 |
13 |
38 |
213 |
88.6 |
0.773 (0.714 -
0.831) |
≥CIN2 (n=110) |
HPV type |
+/+ |
+/- |
-/+ |
-/- |
Agreement [%] |
Kappa [95% CI] |
|
hrHPV |
90 |
6 |
2 |
12 |
92.7 |
0.708 (0.519 - 0.897) |
|
HPV16 |
34 |
4 |
5 |
67 |
91.8 |
0.820 (0.708 - 0.933) |
|
HPV18 |
3 |
1 |
0 |
106 |
99.1 |
0.853 (0.568 - 1.000) |
|
Other hrHPV |
64 |
4 |
5 |
37 |
91.8 |
0.826 (0.717 -
0.935) |
<CIN2 (n=339)
|
HPV type
|
+/+
|
+/-
|
-/+
|
-/-
|
Agreement [%]
|
Kappa [95% CI]
|
|
hrHPV |
151 |
9 |
27 |
152 |
89.4 |
0.788 (0.723 -
0.853) |
|
HPV16 |
26 |
3 |
5 |
305 |
97.7 |
0.854 (0.754 - 0.953) |
|
HPV18 |
10 |
1 |
4 |
324 |
98.5 |
0.792 (0.616 - 0.969) |
|
Other hrHPV |
121 |
9 |
33 |
176 |
87.6 |
0.747 (0.677 -
0.818) |